DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Amarenco P, Goldstein LB, Szarek M. , et al; SPARCL Investigators.
Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
Stroke 2007;
38 (12) 3198-3204
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.